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This paper reports a mixed methods evaluation of a new pathway to improve clinical out-
comes for older people with fractures treated at a hospital Trust in the West Midlands, UK.
The paper focuses specifically on the context surrounding the translation of the new path-
way into practice and the way that external and internal factors influenced its adaptation and
implementation.
Methods
Quantitative analysis used a controlled Interrupted Time Series (ITS) to estimate the effect
of the new pathway on patient complication rate, median length of hospital stay and 30-day
mortality by comparing the pre- and post-intervention periods. ITS data were extracted from
the UK Trauma Audit and Research Network (TARN) database and a patient-level control
group identified using propensity score matching. Parallel qualitative analysis aimed to
examine the context surrounding the new pathway and how external and internal factors
might influence its adaption and implementation into clinical practice. Data were collected
via semi-structured interviews (n = 16) undertaken with staff and clinical stakeholders within
the Trust and were analysed using the COM-B (Capability, Opportunity, Motivation) model
of behaviour.
Results
No statistically significant effects were found for any of the patient outcomes studied in the
controlled ITS analysis. Qualitative data suggest that the lack of effectiveness of the new ini-
tiative can be explained with reference to the capability, opportunity and motivation of inter-
nal Trust stakeholders to engage with the pathway, which created a non-receptive
environment within the Trust.
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Conclusions
Successfully implementing new care pathways in environments that may be non-receptive
to change requires efforts to be put into winning ‘hearts and minds’ within the organisation to
ensure engagement from key stakeholders during intervention development. Evidence
must be provided internally of the way that a given intervention will alleviate the problematic
issues being experienced within the organisation, and external dissemination of results
should be avoided until there is evidence of a positive effect within the organisation where
the new care pathway is first implemented.
Introduction
Innovation that aims to improve healthcare delivery involves complex socio-behavioural pro-
cesses [1]. Such interventions are likely to be highly context-dependent [2], and understanding
the context in which change takes place is central to the success of implementation. Contexts
may be ‘receptive’ or ‘non-receptive’ to change [3]. Receptive contexts are commonly defined
as situations that ‘seem to be favourably associated with forward movement’ [3], whereas non-
receptive contexts are situations where a combination of conditions ‘effectively create block-
ages or resistance to change’ [4]. Non-receptive contexts hinder diffusion of new innovation
[5], and can be associated with a range of interpersonal factors such as the emotional capability
of stakeholders to engage with change [6], or organisational factors such as the procedures for
communication across organisational boundaries [7].
Numerous models exist for measuring behavioural change [8]. Michie et al.’s COM-B
change model–developed following a systematic review of 195 behavioural change interven-
tions–has been used widely to evaluate behaviour change in a range of health and social care
settings. The COM-B framework allows consideration of the psychological, organisational and
system-level factors supporting behaviour change in order to sustain, spread and scale up evi-
dence-based innovation, by highlighting the importance of enhancing capability, opportunity
and motivation to adopt new practice [9]. In this paper, we examine the context and behav-
iours of stakeholders from an evaluation of the implementation and effectiveness of a new
trauma management pathway introduced to a large West Midlands hospital. We use Michie
et al.’s COM-B model as our framework, and: a) consider how the capability, motivation and
opportunity of stakeholders in the organisation to engage with the new pathway impacts on its
effectiveness, and b) evaluate the impact of the receptiveness of the organisational context on
the success of the intervention.
The intervention
The intervention evaluated in this manuscript is a new clinical pathway called HECTOR
(Heartlands Elderly Care, Trauma & Ongoing Recovery), developed by the trauma lead of a
large West Midlands hospital. The older population (� 65 years), is particularly vulnerable to
trauma, and often experiences poor survival when faced with multiple injuries [10]. The likeli-
hood of survival in the older population is further complicated by comorbidities, polyphar-
macy and pre-morbid status, all of which influence an individual’s response to trauma and
may influence the clinician’s attitude towards patient management [11]. Furthermore, older
patients are less able to respond to traumatic injury [12] and have increased levels of trauma-
related mortality [13].
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The HECTOR pathway was underpinned by the broad concepts of holistic and ‘joined up’
care for older patients outlined within the British Geriatrics Society ‘Silver Book’ [14] and in
the NICE guidelines for the management of delirium [15]. It was developed partially as a
response to the changing demographic of patients admitted to the trauma unit at the hospital
(increasing age, frailty and comorbidities, resulting in increased lehgth of hospital stay due to
severe injury patterns requiring complex clinical management), and partially following the
success of a recently introduced national neck of femur fracture pathway that had improved
outcomes for older patients.
The HECTOR pathway aimed to improve outcomes for older people (aged 65+) with frac-
tures treated in Accident & Emergency (A&E) and acute care, by delivering care focused on
the holistic needs of the patient rather than just the presenting injury. In A&E, existing triage
methods were supplemented with enhanced primary and secondary surveys and rapid imaging
access. A new screening tool, the ‘silver survey’, aimed to identify possible medical causes for
injuries and risk factors for delirium and other complications. For patients admitted to wards,
a new daily assessment tool for use by the multidisciplinary team was introduced, aimed at
proactively preventing and managing complications. This consisted of a short checklist for
staff to assess hydration; eating and toileting; confusion and mental state; thromboprophylaxis;
occult illness, and progress towards recovery. A HECTOR staff training programme was devel-
oped and implemented from September 2014 for staff across all disciplines involved in deliver-
ing the pathway.
The evaluation
We undertook a mixed methods evaluation of the effectiveness and implementation of the
HECTOR pathway. The evaluation team was independent from the clinical team at the hospi-
tal, and played no role in the design, development or implementation of the HECTOR path-
way itself. Instead, the evaluation aimed to assess both patient and process outcomes using
both quantitative and qualitative approaches. Quantitative analysis assessed the effectiveness of
the new pathway by exploring impacts on patient outcomes (complication rates, 30 day mor-
tality and length of hospital stay) by comparing outcomes before and after the change in care
delivery.
In parallel, semi-structured interviews with staff and stakeholders at the Trust aimed to
understand their experiences of managing and delivering the pathway, the context and climate
within which the pathway was introduced, and how internal and external forces may have
affected pathway implementation and effectiveness. As the new pathway involved both the
adaptation of existing clinical practices (e.g. fast-tracked imaging) and the introduction of
some new practices (e.g. the silver survey), the evaluation used the COM-B analytical frame-
work [9] to explore how effectiveness was affected/mediated by the context in which the path-
way was implemented.
Materials and methods
The study was approved by the NRES North West Greater Manchester West Research Ethics
Committee (Ref: 14/NW/1496). Approval was also obtained from the research governance
office of the participating hospital Trust.
Quantitative data
The aim of the quantitative analysis was to assess the effectiveness of HECTOR on three
patient-level outcomes: the primary outcome was complication rate (the proportion of patients
with one or more of seven complications: C Difficile, MRSA, bronchopneumonia/lower-
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respiratory tract infection, urinary tract infection, pulmonary embolism, deep vein thrombosis
(DVT) and pressure sore). Median length of hospital stay and 30-day mortality are also
reported. A controlled interrupted time-series analysis (ITS) was undertaken allowing the pre-
and post-intervention periods to be compared, along with an external control group populated
using matched data from the UK Trauma Audit and Research Network (TARN) database.
Months were chosen as the unit of analysis, comparing a 32 month pre-intervention period
(01/01/2012 to 31/08/2014) with a 40 month post-intervention period (01/09/2014 to 31/12/
2017). Control patient data were obtained from all 152 trauma units in England, extracted
from the UK Trauma Audit and Research Network (TARN) database (Box 1).
A potential patient-level control group of 86,314 patients was identified, followed by pro-
pensity score matching based on nearest neighbour pair matching to identify appropriate
patients for inclusion on the basis of baseline patient characteristics (age, gender, comorbidity,
entrapment at scene, mechanism of injury (MOI), penetrating injury, year and month of
admission). For each outcome, the ITS analysis assumed an a priori intervention effect which
included a change in level and/or a change in slope. The “itsa” command in Stata v14 was used
for the ITS analysis [16], using Newey-West standard errors and the number of patients admit-
ted in the relevant month as the analytical weight, to reflect the variability in admissions on a
month-by-month basis. As three outcomes were used, a p-value of<0.0167 was considered
statistically significant.
Statistical power. The power to detect a change in complication rate from a baseline of
40% was estimated using a simulation over 1,000 replications of an ITS analysis with Newey-
West standard errors in R, in which the standard deviation of the baseline complication rate
was assumed to be 10%. Two possible outcomes were used: 1) a level effect of -5 percentage
points but no further change, and 2) a level effect of -1 percentage points and a time effect to
produce a further -4 percentage point change over 12 months. Given a total of 72 time periods
(32 pre- and 40 post-intervention), the study was underpowered, with an estimated statistical
power of 24% for the first outcome and 31% for the second (alpha = 0.05).
Box 1. The Trauma Audit and Research Network (TARN)
The Trauma Audit & Research Network (TARN) is a collaboration of hospitals from
England, Wales, Ireland and parts of Europe. TARN collects data from all hospital Trusts
via an online recording system. Cases are created and given a unique reference number
and data are entered in a specific format (https://www.tarn.ac.uk/content/downloads/
53/Procedures%20manual.pdf). For each episode, data are collected with reference to
the pre-hospital episode, Emergency Department care (including imaging and proce-
dures undertaken), operative management, critical care management and ward-based
care. Information is collected regarding discharge destination, inpatient complications
and TARN themselves generate Injury Severity Scores (ISS) and Probability of Survival
(Ps) for each patient. In order for patients to be eligible for TARN data entry, they must
meet the following criteria: be admitted for >72 hours; be transferred and then admitted
for >72 hours; be admitted to critical care, irrespective of length of stay, or suffer death
as an inpatient. If they meet such criteria, a patient episode is only created if they have
suffered from specific types of injury (burn, facial fracture, femoral fracture, foot or toe:
joint or bone, hand or finger: joint or bone, inhalation, joints, limb fracture—excluding
femur, muscle, tendon or ligament, nerve, pelvis, skin, spine, vessel). For this evaluation,
a further inclusion criterion was that patients had to be at least 65 years old.
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Qualitative data
The qualitative evaluation aimed to examine the context surrounding the translation of the
new pathway and how external and internal factors might influence its adaption and imple-
mentation into clinical practice. Semi-structured interviews were undertaken with staff and
clinical stakeholders in a number of roles and at different levels of the Trust organisational
hierarchy, to capture a range of perspectives on the new pathway and its adoption.
Participants were asked how they experienced HECTOR, their perceptions of the benefits
and challenges, and how the new pathway influenced their work. Given the challenging back-
drop to the implementation of HECTOR, the decision to use the COM-B framework to aid the
evaluation’s interpretation of pathway implementation was made a priori, and the topic guide
(S1 File) was structured so that the chronology of HECTOR and its impacts could be explored,
by asking participants about the development of HECTOR, its implementation, impacts on
clinical practice/patients/other staff, and their views about the role of the organisation and
leadership in establishing the pathway at the Trust. Interviews took place in the hospital and
lasted between 30–60 minutes. All were audio-recorded, and recordings were transcribed
verbatim, with transcripts proof-read against recordings by the member of the research team
who conducted the interview. Written informed consent was obtained from all interview
participants.
Data analysis began with a fine-grained reading of the data and the inductive development
of themes [17, 18]. Once this was complete, the research team met to discuss the results. Inter-
view transcripts were analysed using the key domains of the COM-B framework to understand
the way respondents described their capability, opportunity and motivation to adopt the new
pathway. In using this method, we engaged in deductive reasoning, linking our inductive
themes with existing concepts and frameworks [19].
Results
Quantitative results
Patient characteristics. TARN data were available for 876 patients admitted to the Trust.
Propensity score matching produced two groups of 746 each (matching rate 85%) with well-
balanced baseline covariates (Table 1). However, there was evidence that patients at the Trust
had more severe injuries in the pre-intervention period than control patients.
Impact of HECTOR on complications, length of stay and mortality. Table 2 presents
the results of the controlled ITS. The predicted proportion of patients with one or more com-
plications was increasing at around the same rate in the pre-intervention period at the Trust
and control hospitals, although the rate at the start of data collection was higher at the Trust.
The intervention appears to have had an initial ‘level’ effect in reducing the complications rate
at the Trust (when it increased slightly at control hospitals) and to have reversed the pre-inter-
vention upward trend (at a faster rate than at control hospitals), although these results were
not statistically significant.
Predicted length of stay was decreasing (non-significantly) in the pre-intervention period at
a similar rate in both the Trust and control hospitals. While there was a small ‘level’ effect of
the intervention at control hospitals, the equivalent effect at the Trust was smaller, although
none of these effects were statistically significant. In the post-intervention period, the predicted
length of stay at control hospitals decreased by 0.2 days per month, which was statistically sig-
nificant, whilst the monthly decrease at the Trust was much smaller, such that the length of
stay achieved at the point of the intervention was almost unchanged in the post-intervention
period.
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Predicted mortality was decreasing slightly in the pre-intervention period at the Trust but
was not changing at control hospitals. The only statistically significant result was a ‘level’
increase in the mortality rate at control hospitals of just over 10 percentage points. The ‘level’
Table 1. Descriptive statistics by time period and group after propensity score matching.
Variable Pre-intervention Post-intervention Univariate comparison (pre-intervention)a
Control Trust Control Trust
Dates 01/01/2012 to 31/08/2014 01/09/2014 to 31/12/2017
Number of patients 237 245 509 501
CHARACTERISTICS
Mean age (SD) 81.6 (8.2) 81.8 (8.3) 81.4 (8.4) 81.9 (8.4) t = 0.24; p = 0.81
Gender: N (%) male 71 (30.0) 87 (35.5) 197 (38.7) 189 (37.7) χ2 = 1.69; p = 0.194
Injury Severity Score: median (IQR)b 9 (9 to 13) 10 (9 to 16) 9 (9 to 16) 9 (9 to 17) Bonnet-Price median p<0.0001
Mode of injury: N (%)
Fall <2m 200 (84.4) 197 (80.4) 430 (84.5) 418 (83.4)
Fall >2m 21 (8.9) 25 (10.2) 54 (10.6) 51 (10.2) χ2 = 1.54; p = 0.672
Vehicle incident 13 (5.5) 18 (7.4) 20 (3.9) 26 (5.2)
Other 3 (1.3) 5 (2.0) 5 (1.0) 6 (1.2)
Most severely injured body region: N (%)
Chest 30 (12.7) 32 (13.1) 53 (10.4) 57 (11.4)
Head 36 (15.2) 46 (18.8) 120 (23.4) 123 (24.6)
Limbs 102 (43.0) 95 (38.8) 199 (39.1) 192 (38.2) χ2 = 2.63; p = 0.757
Spine 49 (20.7) 50 (20.4) 95 (18.7) 100 (20.0)
Multiple 19 (8.0) 22 (9.0) 38 (7.5) 27 (5.4)
Other 1 (0.4) 0 2 (0.4) 2 (0.4)
OUTCOMES
Median LoSc (days): (IQR) 14 (7 to 27) 15 (7 to 31) 12 (7 to 21) 14 (8 to 25)
1+ complications: N (%) 23 (9.7) 51 (20.8) 53 (10.4) 44 (8.8)
30 day mortality: N (%) 12 (5.1) 37 (15.1) 68 (13.4) 70 (14.0)
aBold text indicates statistically significant result at p<0.0167
bIQR = Inter-quartile range
cLoS = length of stay.
https://doi.org/10.1371/journal.pone.0247455.t001
Table 2. ITS comparison of trends in patient outcomes over time and between groups.
Proportion with 1
+ complication(s)a




Intercept (outcome at baseline for Control group) 0.076 (0.075) 17.89 (<0.001) 0.050 (0.147)
Difference in intercepts at baseline (T–Control)b 0.103 (0.085) 3.306 (0.418) 0.130 (0.027)
Time effect pre-intervention in Control group (effect of each additional month from
beginning of data collection)
0.001 (0.604) -0.123 (0.233) 0.000 (0.979)
Difference in time effect pre-intervention (T–Control) 0.001 (0.875) -0.061 (0.755) -0.002 (0.534)
Level effect of intervention in Control group (immediate effect) 0.029 (0.612) 3.204 (0.146) 0.104 (0.011)
Difference in the level effect immediately after intervention (T–Control) -0.099 (0.214) -2.602 (0.477) -0.061 (0.329)
Time effect post-intervention in Control group (effect of each additional month from
intervention)
-0.002 (0.075) -0.202 (<0.001) -0.002 (0.063)
Difference in time effect post-intervention in Control group (T–Control) -0.002 (0.357) 0.172 (0.018) 0.001 (0.620)
aResults shown as co-efficient and p values with significant values (<0.0167) shown in bold
bT = The Trust.
https://doi.org/10.1371/journal.pone.0247455.t002
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increase at the Trust was lower than for the controls, but not significantly so, yet it is plausible
that HECTOR ‘prevented’ a larger increase. There was a subsequent downward trend in mor-
tality at both the Trust and the control hospitals. However, predicted mortality remained
higher at the Trust compared to control hospitals throughout the post-intervention period.
Qualitative results
Sixteen interviews were undertaken between August and December 2014. Interviewee roles
included a Trust Medical Director; Clinical Directors and Senior Emergency Medicine man-
agement (n = 3); Consultants in Emergency Medicine (n = 5), Trauma and Orthopaedics
(n = 1) and Elderly Medicine (n = 2); senior nursing staff (n = 2) and data support officers
(n = 2). The quantitative evaluation of the HECTOR pathway indicated no significant change
as a result of implementation. The qualitative data indicated that the observed lack of effective-
ness of the new pathway may have been negatively impacted by certain stakeholder behaviours
at the Trust in which the pathway was introduced. Themes are presented in Table 3, organised
around the COM-B framework domains of capability, opportunity and motivation for individ-
uals to engage with the new pathway [9].
Capability. The physical capability of colleagues across clinical areas within the Trust to
engage with the new pathway limited its success. One consultant reflected:
“At the end of the day, I can be 15 minutes with this one problem but another 120 problems
I’m not giving my time to, so it’s working out, prioritising what I need to do.” (HEC7)
Physical capability was further impaired by the entrenchment of working patterns that
existed within the organisation and a lack of holistic working between trauma/orthopaedics
and other clinical areas. One nurse commented:
“As far as they’re concerned once they’ve fixed that leg, whether it’s a plaster on, whether it’s a
nailing, whatever they’ve done, as far as they’ve concerned that’s that bit, they’re finished.”
(HEC16)
Opportunity. Social and physical opportunities were created to encourage buy-in to
HECTOR. Social opportunities were attempted through top down efforts to change the culture
of the organisation. These efforts involved a series of strategic meetings to discuss how
Table 3. Internal and external behaviours of stakeholder engagement with pathway.
Capability Physical capability of staff to change behaviour impeded by workload and entrenched patterns of
siloed working
Change to certain staff behaviour impeded by lack of psychological capability of adapting to the new
way of working
Adoption of new pathway limited by psychological capability based on lack of engagement with the
organisation
Opportunity Physical opportunity evidenced by the lack of engagement with the training and publicity of the
pathway amongst staff beyond A&E department
Social opportunity evidenced by the lack of engagement strategically to embed the new pathway in
the organisation’s working practices
Motivation Automatic motivation amongst colleagues within the organisation impeded by concern over risks
presented by introducing new way of working
Reflective motivation within the organisation impeded by concerns from colleagues about external
activities of project lead
https://doi.org/10.1371/journal.pone.0247455.t003
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HECTOR would be embedded across the Trust. However, these meetings were not well
attended. One senior executive reflected:
“There was minimal response to the first meeting: when we had the first meeting, which had
gone out in my name–I was pulling all the power I got, A&E turned up but T&O weren’t
there and Elderly wasn’t there. So I wrote to them all afterwards and said: ‘Come on guys, step
up a bit here!’” (HEC2)
Attempts to create physical opportunities were bottom-up and evidenced through general
teaching sessions at the Trust. The teaching was supplemented by posters placed around the
ward summarising the HECTOR principles:
“We started to put posters around the whole place, like near the site office where the bed man-
agement team worked, a few posters around. I just wanted to publicise what we’re doing to
make people think ‘What is HECTOR?’ So they would ask.” (HEC14)
It appeared that these measures to present the project to other departments beyond A&E
went largely unacknowledged. However, outside the Trust, HECTOR was seen as a positive,
innovative and effective pathway. The project lead was invited to lead training sessions across
the West Midlands trauma network, whose members were enthusiastic and receptive. At the
time of writing, The Royal College of Emergency Medicine had begun the process of adopting
HECTOR into national guidelines, and the new pathway had won awards from the BMJ (2018
winner in the category of Emergency) and West Midlands Clinical Research Network (2017
winner in the category of Improvement project of the year) as well as being a NHS70 Parlia-
mentary Award Winner in 2018 in the category of excellence in urgent and emergency care.
The project lead also used social media to promote the new pathway. HECTOR was fol-
lowed on Twitter by over 1000 individuals. Using social media to engage with HECTOR pro-
vided a social opportunity for individuals to engage with the HECTOR pathway but there
appeared to be minimal engagement from colleagues within the organisation.
Motivation. Internal motivation to engage with the new pathway was limited because
individuals within the Trust were under significant scrutiny during the period in which the
new pathway was introduced, and as a result, the implementation of the pathway was impeded.
One consultant commented:
“If you have paperwork which was never in the contract of [the] doctor to fill out, other paper-
work you don’t feel inclined to fill out the paperwork, or it’s not filled out properly in time,
and the one who fills [in] the paperwork is legally responsible to follow it because of the shift
system this is not working.” (HEC6)
The national recognition HECTOR had gathered further affected the motivation of groups
of clinicians within the Trust to engage with the new pathway. One consultant suggested that
the pathway had not been fully evaluated within the organisation:
“What we don’t know is how good this innovation [is] in our own backyard rather than say-
ing: ‘We’ve got the national course for it’–which is fantastic but it is our backyard where it
needs to put it into practice both in letter and spirit.” (HEC9)
Influential actors within the Trust felt that the new pathway should not have been promoted
nationally before it had been proven successful in the host organisation. The use of social
PLOS ONE Implementing a new clinical pathway in a non-receptive context
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media in particular to promote HECTOR nationally was questioned by colleagues within the
Trust. The external presence of HECTOR and the perceived lack of evidence for effectiveness
within the Trust meant there was less inclination amongst colleagues in Elderly Care and
Trauma and Orthopaedics to engage with the new pathway. For example, one interviewee
commented:
“I mean it’s not just black or white, I suppose, you get things like internet stuff, videos, that
kind of stuff. Yeah, fine, people are happy with all that kind of stuff. It’s when you start getting
into other things like Twitter and whatever, that kind of stuff, people are probably slightly less
so.” (HEC10).
Discussion
The quantitative evaluation of a clinical pathway to improve care for older patients admitted to
the Trust with traumatic injuries aimed to examine the impact of the pathway on patient
related outcomes. However, no statistically significant effects were found for any of the three
patient outcomes studied in a controlled ITS analysis. Qualitative data suggest that the lack of
effectiveness of the HECTOR pathway can be explained with reference to the capability,
opportunity and motivation of internal Trust stakeholders to engage with the pathway, which
created a non-receptive environment for HECTOR within the Trust.
The effect of a non-receptive environment on new innovation
The HECTOR pathway was introduced at a time of considerable change for the hospital, with
severe ongoing clinical and financial pressures throughout the period of the study which
meant that the hospital experienced periods of extensive external scrutiny and multiple
changes to senior leadership. Thus, the environment into which the new pathway was intro-
duced was affected by a series of interrelated factors, many of which could not be readily
addressed. For instance, the timing of implementation hindered the intervention because of
the scrutiny the Trust was under at the time, and because of clinical specialities such as elderly
care and trauma and orthopaedics historically failing to co-operate within change within the
organisation. Introducing a new elderly trauma pathway at a time of organisational stress
meant that attempts to change the behaviour of key stakeholders within the Trust and provide
a receptive environment for pathway implementation were unsuccessful.
As is often the case with changes to clinical pathways, if the context and climate are not con-
ducive at the development phase, implementation of the pathway will face challenges, particu-
larly if the innovation requires radical behavioural change [20]. In the case of the HECTOR
pathway, qualitative data indicate that a non-receptive environment existed in the develop-
ment phase due to the behaviours of stakeholders in the organisation. Some of these could
have been managed, but others represented the influence of institutionalised organisational
routines which were beyond the abilities of the organisation or the project lead to change [21].
Engagement with the pathway by clinicians within the Trust was limited to those who
worked closely with the project lead from the beginning of the project in the A&E department.
These individuals were able to change their behaviour more readily to adopt the new way of
working. Clinicians from other specialities did not engage or change their behaviours. Their
lack of capability to do so was affected by the scrutiny the hospital was under and their own
work pressures, as well as a lack of physical capability (i.e. time pressures) and psychological
capability (i.e. entrenched working patterns). This reflects Michie et al.’s model that
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behavioural change is effected by the physical and psychological capability of stakeholders to
adopt the new behaviours to create a receptive environment for the innovation [9].
As a result of the unreceptive environment within the hospital, the project lead turned to
external networks who were more receptive to the new pathway as they recognised the benefits
of the intervention and were more enthusiastic and motivated about the pathway’s potential
benefits. The project lead therefore focused energy on providing opportunities for external
stakeholders to engage with the new pathway and attempted to effect behavioural change by
constructing legitimacy for the project through stakeholders beyond the auspices of the organi-
sation [22]. However, instead of the recognition that the new pathway had gained momentum
nationally working to leverage support from within the Trust, this external recognition
impacted negatively on the behaviour of internal stakeholders who became less motivated to
engage with the new pathway and who perceived its benefits as remaining unproven within
their local context. As the new pathway gathered support externally, clinicians from other spe-
cialities within the organisation invoked their professional status to justify distancing them-
selves from the new innovation [23] as further attempts to present opportunity for
engagement with the new pathway across the organisation were made internally.
The utility of mixed methods to examine results from complex clinical
interventions
In any mixed methods study, the purpose of mixing qualitative and quantitative methods
should be clear in order to determine how they relate to one another and how the data should
be integrated [24]. Mixed methods studies tend to attempt triangulation approaches to achieve
empirical clarity, or theory building through aligning results from mixed methods data collec-
tion [25, 26].
Our study highlighted the particular value of comparing the qualitative and quantitative
data at the interpretative stage of the research process [27], as this allowed a deeper under-
standing of the organisational context in order to evaluate factors that influenced the observed
quantitative finding with regard to the patient outcomes assessed. In doing so, this led to the
conclusion at the interpretive stage that the unreceptive organisational environment had influ-
enced the degree to which the new pathway was able to demonstrate effectiveness. Although
we cannot prove causality regarding the non-receptive environment as the reason for the
counter-intuitive results of the intervention on patient outcomes, our mixed methods
approach does highlight the value of considering the wider contexts of evaluations of new
interventions, an area which continues to be of much debate [28, 29]. Through applying a
mixed methods approach that focused on wider contextual explanations provided by the quali-
tative data at the interpretive stage of the research process we were able to offer contextual
explanations of our results that highlighted the central role that a unreceptive organisational
environment plays in the success (or lack thereof) of a new innovation.
Implications for practice
The challenges of translating a behaviour change intervention into a non-receptive context
identified in this evaluation suggest several implications for others who may be attempting
similar interventions within their own organisations. First, it is clear that substantial efforts
need to be put into winning ‘hearts and minds’ within the organisation that will be host to any
new intervention, since effective implementation requires ‘buy-in’ and engagement from staff
at all levels of seniority and in all roles. Second, evidence needs to be provided internally of the
way that any proposed intervention may help to alleviate issues that are contributing to prob-
lems within the organisation (e.g. evidence that the new pathway will help to save money or
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improve outcomes that the Trust is being monitored on). This may facilitate the necessary
engagement from staff to implement the intervention effectively. And third, external dissemi-
nation of the results from the QI intervention should be avoided until there is evidence that
the intervention has a positive effect on outcomes in the place where it is first implemented,
otherwise the goodwill of clinical and nursing staff within the host institution may dissipate.
Limitations
There was some evidence of under-reporting to the TARN database. Annual case ascertain-
ment rates ranged from 53% (2013) to 75% (2012) for the evaluation site, and from 60.3%
(2012) to 84.2% (2017) in control hospitals. If the under-reporting was systematic (e.g. the
most seriously injured patients were not included), this could have introduced bias into the
results. The ITS was also substantially underpowered to detect differences in outcomes over
time. There were also some differences in the characteristics of patients who were and were
not matched between the Trust and control hospitals: the matching rate was higher for males,
younger patients and those with limb injuries, and lower for those with injuries caused by a fall
of less than 2m and with head or spinal injuries. There was some evidence that patients at the
Trust had more severe injuries in the pre-intervention period than control patients, which
could explain the differences in outcomes between the two groups in this period (higher com-
plication rates, length of stay and 30-day mortality at the Trust compared to control pre-inter-
vention). Nevertheless, the matching process did produce well-balanced groups and enabled a
controlled ITS analysis to be undertaken, which was the most robust approach possible in the
absence of a randomised controlled trial design.
Conclusions
Our evaluation indicates two broad conclusions. First, the importance of considering the
effects of non-receptive environments on the success of new interventions. Second, an
acknowledgement of the value of employing mixed methods and using qualitative data within
evaluations of QI interventions to help provide explanations at the interpretive stage of the
research process. This allows evaluation to consider the wider contextual factors associated
with intervention development and implementation that might influence the observed effects,
over and above those indicated purely by clinical outcomes.
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